Boomi Announces EMEA 2025 Customer Innovation Award Winners
8.10.2025 11:00:00 EEST | Business Wire | Press release
Boomi™, the leader in AI-driven automation, today announced the winners of its EMEA Customer Innovation Awards, recognized at its 2025 Boomi World Tour stop in London.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251008061493/en/
Boomi Announces EMEA 2025 Customer Innovation Award Winners
The awards celebrate organizations that are reimagining how business is done — using the Boomi Enterprise Platform to unify systems, orchestrate data, and power automation at scale. This year’s winners were chosen for their measurable business impact, digital transformation, modernization initiatives, and leadership in preparing for, and thriving in, the era of agentic AI.
2025 EMEA Award Winners include:
Sandoz — EMEA Regional Award: Sandoz made enterprise integration and API management a pillar of its divestiture programme, standardising on Boomi to replace disparate legacy tools with a unified, governed platform. Working with Boomi and a strategic delivery partner, Sandoz executed a best-practice migration that met TSA milestones, reduced operational risk and complexity, and accelerated secure data exchange across business units and partners — establishing a scalable foundation for post-separation growth.
- Aramex — Supply Chain Innovation Award: Aramex unified its global logistics estate on a cloud-based integration layer powered by Boomi, enabling same- and next-day delivery, omnichannel engagement (mobile, WhatsApp, web), and automated partner onboarding — accelerating time-to-market while strengthening resilience and sustainability through smarter routing and ESG data automation.
- Convex Insurance — Broker Experience Excellence Award: Convex Insurance digitised the underwriting value chain with Boomi Integration and API management, enabling real-time, accurate data exchange across multiple distribution partners — dramatically shortening quote turnaround and delivering a market-leading broker experience with a lean, modern operating model.
- Decathlon — Retail Agility & Productivity Award: Decathlon implemented an event-driven integration fabric with Boomi that harmonises retail order flows across ERP, WMS, logistics, and WCS (mechanization partners) — shortening development cycles from weeks to days, scaling to 100+ integrations, and reliably processing millions of messages per day to keep logistics synchronised globally.
- DS Smith — AI-Enabled Excellence Award: DS Smith is “redefining packaging for a changing world” by transforming its legacy data integration capability into a Boomi-powered, cloud-native, scalable backbone for real-time data and AI innovation. Using generative AI to design, map, and test 5,000 existing B2B and application flows, Hitachi and DS Smith have significantly reduced the risk, cost, and time that a non-AI migration would have incurred. The first wave of critical business integrations is now fully live on Boomi and the service team is open for business to meet a backlog of net-new API first digital requirements.
- JDE Peet’s — Real-Time Operations Insight Award: JDE Peet’s has introduced an Agentic AI Layer into its integration landscape, powered by the Solace Agent Mesh and seamlessly integrated through Boomi. This initiative will bring real-time visibility and actionability to order management and supply chain operations. Business-capability agents securely traverse enterprise systems via established integration guardrails to answer complex questions and generate on-the-fly reports. The result is faster issue resolution, cleaner and better-monitored integrations, and a step-change in productivity and decision speed.
Given the exceptional quality and volume of nominations for this year’s EMEA Customer Innovation Awards, Boomi is also proud to recognize and celebrate the program’s finalists. These organizations, including Culina Group and SHV Energy, among other leading innovators, have showcased outstanding use of the Boomi Enterprise Platform, setting new standards of excellence and establishing themselves as leaders in their industries.
“The recipients of the 2025 Boomi EMEA Customer Innovation Awards show what’s possible when organisations connect, integrate, and automate on a unified platform. With the Boomi Enterprise Platform, they are accelerating adoption of agentic AI,” said Adrian Trickett, Vice President and General Manager, EMEA, at Boomi. “We commend these organisations for embracing agentic transformation — empowering systems and people to act with greater autonomy and intelligence. Their efforts are delivering better outcomes every day for their organisations, customers, and partners.”
Additional Resources
- Learn more about the Boomi Enterprise Platform
- Explore the Boomiverse Community
- Follow Boomi on X (Twitter), LinkedIn, Facebook, and YouTube
About Boomi
Boomi, the leader in AI-driven automation, enables organizations worldwide to connect everything, automate processes, and accelerate outcomes. The Boomi Enterprise Platform — including Boomi Agentstudio — unifies integration and automation along with data, API, and AI agent management, in a single, comprehensive solution. Trusted by over 25,000 customers and supported by a network of 800+ partners, Boomi is driving agentic transformation — helping enterprises of all sizes achieve agility, efficiency, and innovation at scale. Discover more at boomi.com.
© 2025 Boomi, LP. Boomi, the ‘Boomi’ logo, the ‘B’ logo, and Boomiverse are registered trademarks of Boomi, LP or its subsidiaries or affiliates in the US and other countries. All rights reserved. Other names or marks may be the trademarks of their respective owners.
View source version on businesswire.com: https://www.businesswire.com/news/home/20251008061493/en/
Contacts
Media Contact
Elliot Harrison
Boomi Corporate Communications
elliot.harrison@boomi.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
www.businesswire.com

Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 20:52:00 EEST | Press release
International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he has served as pro bono counsel to five Nobel Peace Prize laureates. The New York Times has referred to him as "The Extractor" for his work freeing political prisoners worldwide. Genser's decision to support Yim Leak's team comes as the businessman faces an asset freeze exceeding 20 billion baht (more than U
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 18:38:00 EEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli ® (Relacorilant)18.9.2026 15:00:00 EEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu ® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 15:00:00 EEST | Press release
Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at the 2025 European Society for Medical Oncology (#ESMO25) Congress and subsequently published in The New England Journal of Medicine. The recommendation will now be reviewed by the European Commission, which has the authority to grant marketing authorizations for medicines in the EU. In DES
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca ® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 13:58:00 EEST | Press release
Alfasigma S.p.A, a global pharmaceutical company with a focus on innovation in rare disease and specialty care in areas where there is significant unmet patient need, today announced that the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP) has issued a positive opinion for Jyseleca® (filgotinib), an oral, once-daily JAK1 preferential inhibitor, for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy. Following this positive opinion, the application is now referred to the European Commission (EC) for final action. The EC’s decision is expected in the next weeks. “At present, half of people living with axSpA fail to adequately respond to treatment, leaving them with years of preventable struggle with persistent pain and other impactful symptoms,” said Daniele D'Ambrosio, Chief Development Officer, Alfasigma. “This
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom